CAS 20666-12-0|LUMINOL SODIUM SALT
| Common Name | LUMINOL SODIUM SALT | ||
|---|---|---|---|
| CAS Number | 20666-12-0 | Molecular Weight | 200.15 |
| Density | 1.433g/cm3 | Boiling Point | 621.9ºC at 760mmHg |
| Molecular Formula | C8H7N3NaO2+ | Melting Point | 319-320ºC |
| MSDS | ChineseUSA | Flash Point | 329.9ºC |
| Symbol | GHS07 | Signal Word | Warning |
Names
| Name | 3-aminophthalhydrazide monosodium salt |
|---|---|
| Synonym | More Synonyms |
LUMINOL SODIUM SALT BiologicalActivity
| Description | Luminol sodium salt is a versatile chemical that exhibits chemiluminescence, with a striking blue glow, when mixed with an appropriate oxidizing agent. |
|---|---|
| Related Catalog | Signaling Pathways >>Others >>OthersDye ReagentsResearch Areas >>Others |
| References | [1]. Luminol, wikipedia |
Chemical & Physical Properties
| Density | 1.433g/cm3 |
|---|---|
| Boiling Point | 621.9ºC at 760mmHg |
| Melting Point | 319-320ºC |
| Molecular Formula | C8H7N3NaO2+ |
| Molecular Weight | 200.15 |
| Flash Point | 329.9ºC |
| PSA | 88.84000 |
| LogP | 0.00890 |
| InChIKey | GBOXDRMCEVPUSV-UHFFFAOYSA-M |
| SMILES | Nc1cccc2c(=O)[nH]nc([O-])c12.[Na+] |
Safety Information
| Symbol | GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H315-H319-H335 |
| Precautionary Statements | P261-P305 + P351 + P338 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
| Hazard Codes | Xi: Irritant; |
| Risk Phrases | R36/37/38 |
| Safety Phrases | S26-S36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| HS Code | 2933990090 |
Customs
| HS Code | 2933990090 |
|---|---|
| Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
Articles10
More Articles| Assessment of the translational value of mouse lupus models using clinically relevant biomarkers Transl. Res. 163(6) , 515-32, (2014) Lupus is an autoimmune disease with a poorly understood etiology that manifests with a diverse pathology. This heterogeneity has been a challenge to clinical drug development efforts. A related diffic... | |
| Oral treatment with the herbal formula B307 alleviates cardiac toxicity in doxorubicin-treated mice via suppressing oxidative stress, inflammation, and apoptosis. Onco. Targets Ther. 8 , 1193-210, (2015) This study aimed to investigate whether the herbal formula B307 could alleviate doxorubicin (DOX)-induced acute cardiotoxicity. If so, we further unraveled possible molecular mechanisms of cardiac pro... | |
| Gold drug auranofin could reduce neuroinflammation by inhibiting microglia cytotoxic secretions and primed respiratory burst. J. Neuroimmunol. 276(1-2) , 71-9, (2014) Neuroinflammation contributes to the pathogenesis of neurological disorders. Anti-inflammatory treatments could potentially be used to slow down the progression of these diseases. We studied the anti-... |
Synonyms
| 5-Amino-2,3-dihydrophthalazine-1,4-dione,sodium salt |
| Natrium-3-amino-phthalhydrazid |
| 3-Aminophthalhydrazide,5-Amino-2,3-dihydro-1,4-phthalazinedione |
| LUMINOL SODIUM SALT HG |
| 3-Aminophthalhydrazide monosodium salt |
| 5-Amino-2,3-dihydro-phthalazin-1,4-dion,Natrium-Salz |
| Tamirite |
| Luminol sodium salt |
| 5-amino-2,3-dihydro-phthalazine-1,4-dione,sodium-salt |
| 3-AMINOPHTHALHYDRAZIDE SODIUM SALT |
| Galavit |
| 1,4-Phthalazinedione, 5-amino-2,3-dihydro-, sodium salt (1:1) |
| MFCD00161491 |
| Luminol Mono Sodium Salt |
| Tamerit |
| Luminol (sodium salt) |
| 3-AMinophthalhydrazide sodiuM |
| Sodium 5-amino-4-oxo-3,4-dihydro-1-phthalazinolate |
| SODIUM LUMINOL |
